BioVille - the health and care incubator on the university campus in Diepenbeek - recently officially opened its third wing. With this 2,000 m² expansion, BioVille strengthens its position as a leader in BioTech, MedTech and Digital Health. The new wing focuses specifically on scale-ups and is a logical next step to make BioVille a dynamic business district, all within the wider context of the Health Campus. It involves a total investment of 4,319,500 euros, originating from ERDF, the Province of Limburg and BioVille with its shareholders LRM, UHasselt and POM Limburg. In a few weeks, InvoX Pharma, the medtech company under international control since 2021, will move in. Belgian Rejuvenate Biomed will also move to the brand new wing this spring. Shareholders LRM, POM Limburg and UHasselt, together with Flemish Minister for Economy and Innovation, Jo Brouns, are already excited about this new milestone.